ArticleCureus2025
Comparative Evaluation of Breast Ultrasonography and Cytohistopathology in Diagnosing Breast Diseases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBreast diseases include benign and malignant lesions, wherein benign ones are more common than malignant ones. Early differentiation is fundamental in low-resource environments.
objectiveThe objective of this study is to determine the diagnostic accuracy of ultrasonography compared with cytohistopathology in differentiating benign and malignant breast lesions.
methodsA cross-sectional study was conducted at the Pakistan Health & Research Forum between July 2024 and January 2025. One hundred and twenty-five newly diagnosed cases of breast lesions that had been treated with both ultrasonography and cytohistopathology assessment were included. Parameters of diagnostic accuracy, such as sensitivity and specificity, predictive values, and accuracy, were determined. To test the view of agreement, the chi-square and the McNemar tests were employed.
resultsOut of 125 participants (mean age: 43.8 with a standard deviation of 12.4 years), the histopathology of the tumor of 71 participants (56.8%) showed malignant lesions, and 54 participants (43.2%) had benign lesions. The sensitivity was 92.2 percent, specificity 96.7 percent, positive predictive value 96.7 percent, negative predictive value 92.2 percent, and diagnostic accuracy 94.4 percent. The results revealed a statistically significant correlation between malignancy and the increase in age (p < 0.001). There was a significant association in the chi-square test (p < 0.001) and in the McNemar test showing the diagnostic agreement (p = 0.453).
conclusionUltrasonography is highly reliable in terms of diagnostics and can be used as a first-line procedure when making a distinction between benign and malignant lesions in the breast, especially where histopathology is not readily available. It can also become a part of the clinical practice to improve early diagnoses and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.